CompletedNot Applicable

Antenatal Body Shape Index and Pregnancy Complications

Turkey (Türkiye)170 participantsStarted 2023-09-01

Plain-language summary

Background/aim: Gestational diabetes (GDM), gestational hypertension (GHT) and preeclampsia are common complications of pregnancy. In this study, it was aimed to determine the relationship between body shape index (ABSI), calculated based on antenatal measurements of the height, weight and waist circumference, and GDM, GHT and preeclampsia. Materials and methods: 170 patients at 6-16th weeks of gestation were prospectively analyzed. Body mass index (BMI) and ABSI were calculated. Patients were analyzed according to the presence of GDM, GHT and preeclampsia at follow-up. Our study is the first in terms of its subject and makes a significant contribution to the literature.

Who can participate

Age range18 Years – 43 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Having a singleton pregnancy * Pregnancy follow-up and birth must have taken place at Bolu Abant İzzet Baysal University Training and Research Hospital. * Voluntary informed consent form must be signed to participate in the study. Exclusion Criteria: * Multiple pregnancies * Additional systemic and chronic diseases (chronic hypertension, DM, hepatic diseases such as cholestasis, cardiac diseases, rheumatic diseases, renal diseases…) * History of Gestational Diabetes, Gestational Hypertension and Preeclampsia in previous pregnancies

What they're measuring

Calculation of body shape index at 6-16 weeks of gestation

Timeframe: 6-16 weeks of gestation

Trial details

NCT IDNCT07022158

SponsorAbant Izzet Baysal University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-03-01

View on ClinicalTrials.gov More Gestational Complications trials